P2Y12 inhibitor monotherapy vs dual antiplatelet therapy after deployment of a drug-eluting stent: the SHARE randomized clinical trial (vol 7, e240877, 2024)

被引：0
作者：
Min, P. K.
Kang, T. S.
Cho, Y. H.
机构：
来源：
JAMA NETWORK OPEN | 2024年 / 7卷 / 08期
关键词：
D O I：
10.1001/jamanetworkopen.2024.34909
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 2 条
[1]   P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy After Deployment of a Drug-Eluting Stent: The SHARE Randomized Clinical Trial (vol 7, e240877, 2024) [J].
Min, P. K. ;
Kang, T. S. ;
Cho, Y. H. .
JAMA NETWORK OPEN, 2024, 7 (04)
[2]   P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy After Deployment of a Drug-Eluting Stent [J].
Min, Pil-Ki ;
Kang, Tae Soo ;
Cho, Yun-Hyeong ;
Cheong, Sang-Sig ;
Kim, Byeong-Keuk ;
Kwon, Sung Woo ;
Park, Woo Jung ;
Lee, Jung-Hee ;
Kim, Wonho ;
Lee, Wang-Soo ;
Yoon, Young Won ;
Lee, Byoung Kwon ;
Kwon, Hyuck Moon ;
Hong, Bum-Kee .
JAMA NETWORK OPEN, 2024, 7 (03) :E240877
1